Literature DB >> 21857178

Overt hyperthyroidism and hypothyroidism during pregnancy.

Alex Stagnaro-Green1.   

Abstract

The present manuscript provides a definition for, and evaluates the prevalence and maternal/fetal/child impact of, overt hyperthyroidism and overt hypothyroidism. The prevalence of overt hyperthyroidism is 0.5% and the prevalence of overt hyperthyroidism is 0.3%. Overt maternal hyperthyroidism is associated with heart failure, preeclampsia, preterm delivery, still birth, and neonatal mortality. Overt maternal hypothyroidism is associated with preeclampsia, gestational hypertension, cretinism, fetal deaths, and spontaneous abortion. A cost-effective analysis for screening and treating overt thyroid disease during pregnancy is warranted.

Entities:  

Mesh:

Year:  2011        PMID: 21857178     DOI: 10.1097/GRF.0b013e3182272f32

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  28 in total

1.  Prevalence of overt and subclinical thyroid dysfunction among pregnant women and its effect on maternal and fetal outcome.

Authors:  Sangita Nangia Ajmani; Deepa Aggarwal; Pushpa Bhatia; Manisha Sharma; Vinita Sarabhai; Mohini Paul
Journal:  J Obstet Gynaecol India       Date:  2013-12-01

2.  Associations between thyroid autoantibody status and abnormal pregnancy outcomes in euthyroid women.

Authors:  Liang-Miao Chen; Qian Zhang; Guang-Xin Si; Qing-Shou Chen; En-ling Ye; Le-Chu Yu; Meng-Meng Peng; Hong Yang; Wen-Jun Du; Chi Zhang; Xue-Mian Lu
Journal:  Endocrine       Date:  2014-09-11       Impact factor: 3.633

3.  2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children.

Authors:  John Lazarus; Rosalind S Brown; Chantal Daumerie; Alicja Hubalewska-Dydejczyk; Roberto Negro; Bijay Vaidya
Journal:  Eur Thyroid J       Date:  2014-06-07

4.  Effect of maternal chronic disease on obstetric complications in twin pregnancies in a United States cohort.

Authors:  Emily Werder; Pauline Mendola; Tuija Männistö; Jennifer O'Loughlin; S Katherine Laughon
Journal:  Fertil Steril       Date:  2013-03-29       Impact factor: 7.329

5.  Does exposure to flame retardants increase the risk for preterm birth?

Authors:  Morgan R Peltier; Hschi-Chi Koo; Darios Getahun; Ramkumar Menon
Journal:  J Reprod Immunol       Date:  2014-12-02       Impact factor: 4.054

6.  Therapeutic exploration of betulinic acid in chemically induced hypothyroidism.

Authors:  Muhammad Afzal; Imran Kazmi; Susmita Semwal; Fahad A Al-Abbasi; Firoz Anwar
Journal:  Mol Cell Biochem       Date:  2013-10-05       Impact factor: 3.396

7.  Antecedents of neonatal encephalopathy in the Vermont Oxford Network Encephalopathy Registry.

Authors:  Karin B Nelson; Peter Bingham; Erika M Edwards; Jeffrey D Horbar; Michael J Kenny; Terrie Inder; Robert H Pfister; Tonse Raju; Roger F Soll
Journal:  Pediatrics       Date:  2012-10-15       Impact factor: 7.124

Review 8.  Thyroid disorders in pregnancy.

Authors:  Alex Stagnaro-Green; Elizabeth Pearce
Journal:  Nat Rev Endocrinol       Date:  2012-09-25       Impact factor: 43.330

9.  Accumulation and endocrine disrupting effects of the flame retardant mixture Firemaster® 550 in rats: an exploratory assessment.

Authors:  Heather B Patisaul; Simon C Roberts; Natalie Mabrey; Katherine A McCaffrey; Robin B Gear; Joe Braun; Scott M Belcher; Heather M Stapleton
Journal:  J Biochem Mol Toxicol       Date:  2012-11-08       Impact factor: 3.642

10.  A 2018 Italian and Romanian Survey on Subclinical Hypothyroidism in Pregnancy.

Authors:  Roberto Negro; Roberto Attanasio; Enrico Papini; Rinaldo Guglielmi; Franco Grimaldi; Vincenzo Toscano; Dan Alexandru Niculescu; Diana Loreta Paun; Catalina Poiana
Journal:  Eur Thyroid J       Date:  2018-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.